Summary

The United States has always been a global leader in healthcare innovation, and this applies to respiratory care devices. With an aging population, a rising frequency of chronic respiratory disorders, and increased awareness of the importance of respiratory health, the market for respiratory care equipment in the United States has grown significantly in recent years. The respiratory care devices market in the United States includes a wide range of products and devices designed to help people with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea, as well as those recovering from surgery or dealing with acute respiratory issues. These pieces of equipment include ventilators, nebulizers, continuous positive airway pressure (CPAP) devices, oxygen concentrators, and others. The prevalence of chronic respiratory disorders, such as asthma and COPD, has increased significantly in the United States, owing mostly to factors such as smoking, air pollution, and an aging population. As a result, there is a growing demand for respiratory care devices to help people with these disorders maintain and improve their quality of life. As older people are more prone to respiratory ailments and frequently require long-term care and support, the demographic trend toward an older population has raised demand for respiratory care devices. Advances in technology have led to the development of more efficient and user-friendly respiratory care devices. These innovations include portable and wearable devices, remote monitoring capabilities, and improved interfaces, making it easier for patients to manage their conditions.

According to the research report "United States Respiratory Care Devices Market Overview, 2028," published by Bonafide Research, the United States Respiratory Care Devices market was valued more than USD 5 Billion in 2022. Integration of respiratory care equipment with telehealth platforms would allow for remote monitoring and consultation, giving patients real-time support while lowering the burden on healthcare facilities. The United States is a medical technology innovation hotspot. Companies in the United States are at the forefront of designing and producing innovative respiratory care products that include the most recent technological advances. Devices with advanced sensors, data connectivity, and user-friendly interfaces are examples of this. The United States makes significant investments in healthcare research and development. As a result of this commitment to innovation, respiratory care technologies are always improving. In order to drive improvements in this subject, American research institutes and colleges cooperate with industry leaders. The United States invests much in medical research and development, both through government institutions such as the National Institutes of Health (NIH) and commercial groups. This money supports respiratory research as well as the development of innovative respiratory care equipment. Respiratory therapists are a specialized healthcare profession in the United States. These experts are responsible for managing and operating respiratory care devices, educating patients, and optimizing therapy strategies. The American Association for Respiratory Treatment (AARC) and the American Thoracic Society (ATS) are industry associations in the United States that promote research, education, and advocacy for respiratory health and treatment. These organizations contribute to the development of industry standards and recommendations.

Based on product type market is divided into therapeutic devices, monitoring devices, diagnostic devices and consumables and accessories. Among them market is majorly dominated by therapeutic devices with significant market share. Chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea are major public health issues in the United States. COPD, for example, affects millions of Americans and necessitates continual monitoring and treatment. Therapeutic devices are critical instruments for effectively controlling certain disorders. Therapeutic respiratory devices are specially designed to help people manage various respiratory diseases. Inhalers, nebulizers, and positive airway pressure devices, for example, are routinely used to relieve symptoms, improve lung function, and improve overall respiratory health. Individuals with severe respiratory disorders or those who have trouble utilizing inhalers require the use of nebulizers. They turn liquid medication into a fine mist that may be inhaled, ensuring effective drug administration, especially for youngsters, the elderly, and patients who have severe restrictions in their ability to breathe. The United States has witnessed a significant shift toward home healthcare, driven by the desire for cost-effective, patient-centric care. Therapeutic respiratory devices are well-suited for home use, allowing patients to manage their conditions without the need for frequent hospital visits.

In terms of disease indication market includes, chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases and other disease indications. The chronic obstructive pulmonary disease (COPD) is expected to lead the market of United States during the forecast period. COPD is a common and developing health issue in the United States. According to the American Lung Association, roughly 16 million Americans have COPD, and millions more are thought to have undiagnosed COPD. Demand for respiratory care devices is being driven by the rising prevalence of COPD. COPD is a chronic, progressive condition that necessitates continual monitoring and therapy. Patients frequently require respiratory care equipment in order to relieve symptoms, improve lung function, and maintain a high quality of life. Patients rely on these gadgets for long-term care because COPD is incurable. Inhalers are a critical component of COPD therapy. Bronchodilators and anti-inflammatory drugs are delivered directly to the airways, offering immediate relief from symptoms such as shortness of breath and coughing. As one of the most common treatments for COPD, inhalers significantly drive the demand for respiratory care devices. Furthermore, the end user of the industry includes hospitals, ambulatory care centers (ACCs), home care settings and other end user. Among them hospitals are the major end users of respiratory care devices in United States. Hospitals are the primary facilities where individuals with severe respiratory conditions, acute exacerbations of chronic respiratory diseases, or respiratory distress seek immediate medical attention. These patients often require advanced respiratory care devices to stabilize their condition, such as ventilators and high-flow oxygen therapy systems. ICUs in hospitals are equipped to provide specialized care to critically ill patients, including those with severe respiratory issues. Ventilators, non-invasive positive pressure ventilation (NIPPV) machines, and high-flow oxygen systems are commonly used in ICUs to manage respiratory failure and support patients' breathing.

Considered in this report:
• Geography: United States
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• United States Respiratory Care Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type:
• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents